Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/17 → 5/4/20 |
Funding
- Children’s Hospital of Philadelphia
- Eli Lilly and Company
ADVL1515 - Lilly: A Phase 1 Study of LY2606368, a CHK1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors
- Goldman, Stewart (PD/PI)
Project: Research project